Retrospective Cohort Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Sep 21, 2023; 29(35): 5125-5137
Published online Sep 21, 2023. doi: 10.3748/wjg.v29.i35.5125
Table 3 Laboratory results of patients in the two groups (n, %)

Normal group (n = 65)
Abnormal group (n = 148)
P value
Hb (g/L)126.3 ± 16.8126.8 ± 14.60.828
WBC (× 109/L)6.5 ± 2.25.8 ± 1.80.026a
NEUT61.8 ± 11.156.1 ± 10.30.001a
LY26.8 ± 9.829.2 ± 8.20.071
EOS3.9 ± 3.46.2 ± 5.40.001a
BASO0.6 ± 0.40.8 ± 0.50.003a
PLT (× 109/L)212.9 ± 83.3218.6 ± 75.00.621
TP (g/L)67.2 ± 7.572.5 ± 7.9< 0.001a
ALB (g/L)39.4 ± 5.836.7 ± 4.60.001a
TT (s)16.9 ± 1.217.4 ± 1.60.012a
IgG1 (mg/dL)872.6 ± 371.8935.8 ± 319.90.045a
IgG2 (mg/dL)450.4 ± 174.0638.6 ± 241.6< 0.001a
IgG3 (mg/dL)42.70 ± 43.3753.6 ± 58.40.034a
IgG4 (mg/dL)252.7 ± 106.61420.5 ± 1110.9< 0.001a
IgE (IU/mL)231.7 ± 352.5635.6 ± 958.10.002a
IgG (mg/dL)1323.6 ± 503.92062.1 ± 918.9< 0.001a
FLC-κ (mg/dL)306.1 ± 99.7569.6 ± 252.5< 0.001a
FLC-λ (mg/dL)176.4 ± 63.4282.5 ± 124.5< 0.001a
C3 (mg/dL)119.0 ± 45.7100.6 ± 36.20.050
ESR (mm/h)21.1 ± 20.143.4 ± 28.60.002a
ANA (positive)5 (12.5)19 (20.0)0.298
CA19-9 (abnormal)33 (53.0)73 (52.0)0.887